Intrinsic Value of S&P & Nasdaq Contact Us

LumiraDx Limited LMDX NASDAQ

NASDAQ Global Market • Healthcare • Medical - Diagnostics & Research • GB • USD

SharesGrow Score
44/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$1.50
+9275%

LumiraDx Limited (LMDX) has a consensus analyst rating of Buy, based on 4 analysts covering the stock. Of those, 3 recommend buying, 1 recommend holding, and 0 recommend selling.

The analyst consensus price target for LMDX is $1.50, representing a +9,275.0% upside from the current price of $0.016. Price targets range from a low of $1.50 to a high of $1.50.

Analyst Consensus — LMDX

Buy
Strong Buy
0
Buy
3
Hold
1
Sell
0
Strong Sell
0
4 analysts
Price Targets
Consensus$1.50
High$1.50
Low$1.50
Median$1.50
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message